4,870
Views
0
CrossRef citations to date
0
Altmetric
Drug Evaluation

Ravulizumab for the treatment of myasthenia gravis

& ORCID Icon
Pages 235-241 | Received 26 Oct 2022, Accepted 22 Feb 2023, Published online: 08 Mar 2023